Skip to main content
OpenTrials
Completed

NCT Number: NCT01525797

Blood Draw Study for Liver Transplant Patients

The purpose of this study is to see what a lab test will show and if there is a way to predict which patients will be more likely to have rejection after receiving a liver transplant.

Completed

Looking for future studies?

Notify Me

Key information

Age range

17 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Baylor University Medical Center

Dallas, Texas, 752245, United States

About this study

The purpose of this study is simply to see what the new oligonucleotide microarrays will show when comparing the the different patient groups. The results of this study will be one of the first steps In exploring the potential use of this new test.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Received a liver Transplant

Exclusion criteria

  • Received Multiple Organ Transplant

Treatment and study plan

Primary outcomes

  1. Identify signatures predictive of graft rejection or tolerance.

    Time frame: 2 years

    Analyze the pattern of gene expression in patients undergoing solid organ transplantation

Sponsors and collaborators

Lead sponsor

Baylor Research Institute

Other

Registry information

Official study title

Immunomonitoring of Transplant Patients

Important dates

Study start
2002
Primary completion
2013
Study completion
2013
First posted
Feb 3, 2012
Registry last updated
Jan 26, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.